» Articles » PMID: 19632112

Inhibitors of HIV-1 Attachment. Part 3: A Preliminary Survey of the Effect of Structural Variation of the Benzamide Moiety on Antiviral Activity

Abstract

1-(4-Benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione (1a) has been characterized as an inhibitor of HIV-1 attachment that interferes with the interaction of viral gp120 with the host cell receptor CD4. In previous studies, the effect of indole substitution pattern on antiviral activity was probed. In this Letter, the effect of structural variation of the benzamide moiety is described, a study that reveals the potential or the phenyl moiety to be replaced by five-membered heterocyclic rings and a restricted tolerance for the introduction of substituents to the phenyl ring.

Citing Articles

Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry.

Barresi E, Robello M, Baglini E, Poggetti V, Viviano M, Salerno S Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513909 PMC: 10386336. DOI: 10.3390/ph16070997.


The Genesis and Future Prospects of Small Molecule HIV-1 Attachment Inhibitors.

Wang T, Kadow J, Meanwell N, Krystal M Adv Exp Med Biol. 2022; 1366:45-64.

PMID: 35412134 DOI: 10.1007/978-981-16-8702-0_4.


Innovation in the discovery of the HIV-1 attachment inhibitor temsavir and its phosphonooxymethyl prodrug fostemsavir.

Wang T, Kadow J, Meanwell N Med Chem Res. 2021; 30(11):1955-1980.

PMID: 34602806 PMC: 8476988. DOI: 10.1007/s00044-021-02787-6.


The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities.

Robello M, Barresi E, Baglini E, Salerno S, Taliani S, Da Settimo F J Med Chem. 2021; 64(7):3508-3545.

PMID: 33764065 PMC: 8154582. DOI: 10.1021/acs.jmedchem.0c01808.


Synthesis of diindolylmethane (DIM) bearing thiadiazole derivatives as a potent urease inhibitor.

Taha M, Rahim F, Khan A, Anouar E, Ahmed N, Shah S Sci Rep. 2020; 10(1):7969.

PMID: 32409737 PMC: 7224224. DOI: 10.1038/s41598-020-64729-3.